Alabama

Pharmacist registrations expire December 31, 2022. The Board of Pharmacy is accepting pharmacist license renewals ONLINE ONLY at www.albop.com. The renewal fee is $100 plus $100 for a controlled substance permit. If you are changing your name, send proof of legal name change BEFORE YOU REGISTER ONLINE. If you fail to renew your license by December 31, 2022, but you continue to work as a pharmacist in any way, you will be subject to late fees and discipline. For more information, please contact the Board of Pharmacy directly at 205-981-2280.  

Also in Alabama, please see these updated ALERTS for billing for Stand-alone COVID-19 Vaccine Counseling for Recipients Under Age 21 and billing for Stand-alone Vaccine Counseling to Recipients Under Age 21.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-11-04T11:36:09-04:00November 4, 2022|Alabama|

Alabama

Reminder, Alabama Administrative Rule 420-4-1-.04 requires pharmacists to report to the State Health Officer or designee the dispensing of anti-tuberculosis medications and dispensing of antiretroviral medications to an infant.

Also in Alabama, all previously published expiration dates related to the COVID-19 public health emergency (PHE) are once again extended by the Alabama Medicaid Agency. The new expiration date is the earlier of November 30, 2022, the conclusion of the COVID-19 national emergency, or any expiration date noticed by the Alabama Medicaid Agency through a subsequent ALERT.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-10-28T11:03:41-04:00October 28, 2022|Alabama|

Alabama

Please find an ALERT describing the addition of state-licensed pharmacist Paxlovid prescribing to eligible patients in accordance with the FDA. This ALERT has been disseminated to all enrolled pharmacies.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-10-21T13:04:52-04:00October 21, 2022|Alabama|

Alabama

All previously published expiration dates related to the COVID-19 public health emergency (PHE) are once again extended by the Alabama Medicaid Agency (Medicaid). The new expiration date is the earlier of October 31, 2022, the conclusion of the COVID-19 national emergency, or any expiration date noticed by the Alabama Medicaid Agency through a subsequent ALERT. 

Medicaid is preparing now for the end of the COVID-19 PHE. Medicaid partners can assist in relaying a consistent and simple message to the Medicaid recipients by sharing key messages from the Agency in your newsletters, social media posts, and other means of communication. To learn more about the “Yellow Postcard” campaign and the Communication Toolkit, please visit here. 

Also in Alabama, effective October 1, 2022, the Alabama Medicaid Agency will remove prior authorization (PA) from levalbuterol tartrate HFA (generic Xopenex HFA). Brand Xopenex HFA will now require PA and update the PDL (Preferred Drug List) to reflect the quarterly updates listed here.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-09-16T09:58:39-04:00September 16, 2022|Alabama|

Alabama

The Alabama Medicaid Agency will provide a COVID-19 public health emergency (PHE) update for Medicaid providers and partners on September 15, 2022. Agency representatives will share how the Agency is preparing for the end of the PHE and the return to normal operations. The meeting is offered for attendees both in-person or virtual (online or by phone).  

Medicaid providers, staff, operating state agencies, professional groups, advocacy groups, and all partners who interact with Medicaid recipients are encouraged to attend.  

Also in Alabama, please find the updated Synagis® Criteria for Summer 2022 (as part of the 2021-2022 Season); and the Use of Synagis® in the 2022–2023 Season here.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-08-19T10:46:29-04:00August 19, 2022|Alabama|

Alabama

Alabama Pharmacy Association (APA) has been working with the Department of Insurance as they create a way for pharmacists/pharmacies as well as patients/consumers to file complaints regarding PBMs (Pharmacy Benefits Managers). APA has created two QR codes that can be printed out for easy access. One is for pharmacists/pharmacies and will take you directly to a page on the Department of Insurance website specifically for the purpose of filing a PBM complaint. The other is for patient use. You may find it useful to print this out and place it where patients can easily access it with the camera on their smart phone.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-07-29T10:09:18-04:00July 29, 2022|Alabama|

Alabama

All previously published expiration dates related to the COVID-19 public health emergency (PHE) are being extended by the Alabama Medicaid Agency (Medicaid). The new expiration date is the earlier of August 31, 2022, the conclusion of the COVID-19 national emergency, or any expiration date noticed by the Alabama Medicaid Agency through a subsequent ALERT.  

Medicaid is preparing now for the end of the COVID-19 PHE. Medicaid partners can assist in relaying a consistent and simple message to the Medicaid recipients by sharing key messages from the Agency in your newsletters, social media posts, and other means of communication. To learn more about the “Yellow Postcard” campaign and the Communication Toolkit, please click here 

Also in Alabama, registration is open for the APhA Pharmacy-Based Immunization Delivery Certificate Training Program hosted by Alabama Pharmacy Association (APA). The program is scheduled for Saturday, August 13, from 8 a.m. – 6 p.m. at the APA office in Montgomery. The program is an innovative, intensive, and practice-based CPE activity, based on national educational standards for immunization training from the CDC (Centers for Disease Control). For more information and to register for the full certification course 

Additionally, if it has been longer than three years since you were certified and you want a refresher course or if you need to satisfy the PREP Act’s 2-hour immunization CPE requirement, APA is offering six hours of continuing education in conjunction with the APhA program (minus the shots), which will include the most current immunization recommendations and guidelines. Also, the program has been approved by the Alabama Board of Pharmacy for six hours of consultant credit. For more information and to register for the refresher 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-07-22T11:47:37-04:00July 22, 2022|Alabama|

Alabama

All previously published expiration dates related to the COVID-19 emergency are once again extended by the Alabama Medicaid Agency. The new expiration date is the earlier of July 31, 2022, the conclusion of the COVID-19 national emergency, or any expiration date noticed by the Alabama Medicaid Agency through a subsequent ALERT. A listing of previous Provider ALERTs and notices related to the health emergency is available by selecting the Agency’s COVID-19 page

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-06-17T11:21:30-04:00June 17, 2022|Alabama|

Alabama

Effective July 1, 2022, the Alabama Medicaid Agency will:   

  • Remove prior authorization (PA) from dexmethylphenidate ER (generic Focalin XR). Brand Focalin XR will now require PA.  
  • Update the PDL (Preferred Drug List) to reflect the quarterly updates listed below:   
PDL Additions 
Dexmethylphenidate ER (generic)  Cerebral Stimulants/Agents Used for ADHD (attention deficit hyperactivity disorder) (Long-Acting) 
PDL Deletions 
Adhansia XR  Cerebral Stimulants/ Agents Used for ADHD (Long-Acting) 
Focalin XR  Cerebral Stimulants/ Agents Used for ADHD (Long-Acting) 

               

For additional PDL and coverage information, visit the drug look-up site. 

The Prior Authorization (PA) request form and criteria booklet should be utilized by the prescriber or the dispensing pharmacy when requesting a PA. The PA request form can be completed and submitted electronically on the Agency’s website.  

Incomplete PA requests or those failing to meet Medicaid criteria will be denied. If the prescriber believes medical justification should be considered, the prescriber must document this on the form or submit a written letter of medical justification along with the PA form to Kepro. Additional information may be requested. Staff physicians will review this information. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-06-10T10:32:28-04:00June 10, 2022|Alabama|
Go to Top